Cardiovascular safety and efficacy of combination therapy with metformin and sodium-glucose cotransporter-2 inhibitors versus metformin and sulfonylureas in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Desye Gebrie, Desalegn Getnet, Tsegahun Manyazewal
doi: https://doi.org/10.1101/2020.04.24.20077917

Data Availability

All relevant data are within the manuscript and its supporting information files.

Back to top
Posted April 29, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Cardiovascular safety and efficacy of combination therapy with metformin and sodium-glucose cotransporter-2 inhibitors versus metformin and sulfonylureas in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Desye Gebrie, Desalegn Getnet, Tsegahun Manyazewal
medRxiv 2020.04.24.20077917; doi: https://doi.org/10.1101/2020.04.24.20077917
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area